Gene Symbol | Pearson Correlation Coefficient |
---|---|
NPBWR1 | 0.692 |
FREM3 | 0.682 |
GPR26 | 0.675 |
RELN | 0.659 |
HCRTR1 | 0.645 |
FBLN7 | 0.637 |
HS6ST3 | 0.636 |
GALNTL6 | 0.631 |
PIK3C2G | 0.631 |
PRLHR | 0.622 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
HEBP2 | -0.448 |
ROM1 | -0.416 |
AZGP1 | -0.398 |
OTOS | -0.389 |
AQP1 | -0.381 |
PLIN2 | -0.374 |
TGFB3 | -0.369 |
KIF19 | -0.36 |
ANG | -0.349 |
IFITM2 | -0.349 |
ID | Drug Name | Drug Type | CAS Num | Status | Role |
---|---|---|---|---|---|
DB05332 | Romiplostim | BiotechDrug | 267639-76-9 | Approved | Target |
DB05930 | SB-559448 | Small Molecule | - | Investigational | Target |
DB06210 | Eltrombopag | Small Molecule | 496775-61-2 | Approved | Target |
DB06534 | Thrombopoietin | BiotechDrug | 9014-42-0 | Investigational | Target |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in decreased expression of MPL mRNA" | 18648102 |
C021139 | anagrelide | anagrelide inhibits the reaction [THPO protein results in increased expression of MPL mRNA] | 20586925 |
D018501 | Antirheumatic Agents | Antirheumatic Agents results in increased expression of MPL mRNA | 24449571 |
C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of MPL mRNA | 15761015 |
D001280 | Atrazine | Atrazine results in increased expression of MPL mRNA | 25929836 |
C037689 | benzamide | benzamide analog binds to and results in increased activity of MPL protein | 18396041 |
D001554 | Benzene | Benzene results in decreased expression of MPL mRNA | 19162166 |
D001554 | Benzene | Benzene results in decreased expression of MPL mRNA | 15120971 |
C006703 | benzo(b)fluoranthene | benzo(b)fluoranthene results in decreased expression of MPL mRNA | 26377693 |
C006780 | bisphenol A | bisphenol A results in increased methylation of MPL promoter | 27312807 |
C006780 | bisphenol A | bisphenol A results in decreased expression of MPL mRNA | 25181051 |
D002104 | Cadmium | Cadmium results in decreased expression of MPL mRNA | 24376830 |
C014347 | decitabine | decitabine promotes the reaction [hydroquinone results in increased expression of MPL mRNA] | 22245671 |
C520809 | eltrombopag | eltrombopag binds to and results in increased activity of MPL protein | 21646437 |
C031927 | hydroquinone | decitabine promotes the reaction [hydroquinone results in increased expression of MPL mRNA] | 22245671 |
C031927 | hydroquinone | hydroquinone results in decreased methylation of MPL gene | 22245671 |
C031927 | hydroquinone | hydroquinone results in increased expression of MPL mRNA | 22245671 |
D008748 | Methylcholanthrene | "[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of MPL mRNA" | 25926378 |
C059539 | midostaurin | midostaurin results in increased expression of MPL protein | 19573588 |
D037742 | Nanotubes, Carbon | "[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of MPL mRNA" | 25926378 |
D009532 | Nickel | Nickel results in decreased expression of MPL mRNA | 24768652|2558310 |
D052638 | Particulate Matter | Particulate Matter results in decreased expression of MPL mRNA | 15046786 |
D010416 | Pentachlorophenol | Pentachlorophenol results in increased expression of MPL mRNA | 23892564 |
D011192 | Potassium Dichromate | Potassium Dichromate results in decreased expression of MPL mRNA | 23608068 |
C045950 | propiconazole | propiconazole results in increased expression of MPL mRNA | 21278054 |
D014118 | Toxins, Biological | "Toxins, Biological affects the expression of MPL mRNA" | 19682533 |
D014520 | Urethane | Urethane results in decreased expression of MPL mRNA | 28818685 |
D001335 | Vehicle Emissions | Vehicle Emissions results in decreased expression of MPL mRNA | 15046786 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0004888 | transmembrane signaling receptor activity | - | TAS | 8020956 |
GO:0005515 | protein binding | - | IPI | 24931576 |
GO:0038164 | thrombopoietin receptor activity | - | IMP | 25538044 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0001780 | neutrophil homeostasis | - | IEA | - |
GO:0007166 | cell surface receptor signaling pathway | - | TAS | 8020956 |
GO:0008283 | cell proliferation | - | TAS | 8020956 |
GO:0035702 | monocyte homeostasis | - | IEA | - |
GO:0038163 | thrombopoietin-mediated signaling pathway | - | IEA | - |
GO:0050671 | positive regulation of lymphocyte proliferation | - | IEA | - |
GO:0070527 | platelet aggregation | - | IEA | - |
GO:0071456 | cellular response to hypoxia | - | IEA | - |
GO:1905221 | positive regulation of platelet formation | - | IEA | - |
GO:1990959 | eosinophil homeostasis | - | IEA | - |
GO:1990960 | basophil homeostasis | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005794 | Golgi apparatus | - | IDA | 25538044 |
GO:0005886 | plasma membrane | - | TAS | - |
GO:0005887 | integral component of plasma membrane | - | TAS | 8020956 |
GO:0009986 | cell surface | - | IDA | 25538044 |
GO:0043005 | neuron projection | - | IEA | - |
GO:0043025 | neuronal cell body | - | IEA | - |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-109582 | Hemostasis | IEA |
R-HSA-76002 | Platelet activation, signaling and aggregation | IEA |
R-HSA-76009 | Platelet Aggregation (Plug Formation) | IEA |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
20849660 | Risk factors for development of left ventricular thrombus after first acute anterior myocardial infarction-association with anticardiolipin antibodies. (2010 Sep 19) | Okuyan E | Thromb J |
14633783 | Chronic myeloproliferative disorders. (2003) | Spivak JL | Hematology Am Soc Hematol Educ Program |
9478297 | Anticardiolipin antibodies in pre-eclampsia and intrauterine growth retardation. (1997) | D'Anna R | Clin Exp Obstet Gynecol |
10436101 | Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity. (1999 Aug) | Tuhrim S | Stroke |